TECEOS®
Kit for the preparation of technetium (99mTc) 3,3-diphosphono-1,2-propanedicarboxylic acid (DPD) injection
| Isotope | Technetium (99mTc) |
| Number of radiolabelled preparations | 1 |
| Each vial contains : 3,3-diphospho - 1,2 -propanedicarboxylic acid, tetrasodium salt (DPD) tin (II) - oxide N - (4 - aminobenzoyl) - L - glutamic acid, monosodium salt |
13.0 mg 0.23 mg 1.0 mg |
| Volume of pertechnetate 99mTc to use for reconstitution | 2 to 10 mL |
| Radiochemical purity | ≥ 95 % |
| Storage | 13 months, not above 25°C |
| Stability of labelled product | 8 h at 25°C |
| Activity per vial | 0.37 to 11.1 GBq |
| Indications / Posology | Bone scintigraphy 500 MBq (300 - 700 MBq) |
| Time between injection and examination | Late phase static scintigraphy should be performed not earlier than 2 hours |
| Availability | From stock |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
